Summit Therapeutics Inc.

Summit Therapeutics Inc.verified

SMMT

Price:

$14.01

Market Cap:

$10.86B

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). A...[Read more]

Industry

Biotechnology

IPO Date

2015-03-05

Stock Exchange

NASDAQ

Ticker

SMMT

The Enterprise Value as of June 2026 (TTM) for Summit Therapeutics Inc. (SMMT) is 10.80B

According to Summit Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.80B. This represents a change of -26.38% compared to the average of 14.67B of the last 4 quarters.

Summit Therapeutics Inc. (SMMT) Historical Enterprise Value (quarterly & annually)

How has SMMT Enterprise Value performed in the past?

The mean historical Enterprise Value of Summit Therapeutics Inc. over the last ten years is 2.98B. The current 10.80B Enterprise Value has changed 36.16% with respect to the historical average. Over the past ten years (40 quarters), SMMT's Enterprise Value was at its highest in in the June 2025 quarter at 15.59B. The Enterprise Value was at its lowest in in the December 2019 quarter at 4.60M.

Quarterly (TTM)
Annual

Average

2.98B

Median

536.84M

Minimum

-9778844.90

Maximum

12.93B

Summit Therapeutics Inc. (SMMT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Summit Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 670.07%

Maximum Annual Enterprise Value = 12.93B

Minimum Annual Increase = -2937.21%

Minimum Annual Enterprise Value = -9778844.90

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202512.93B2.05%
202412.67B670.07%
20231.64B72.16%
2022955.35M385.03%
2021196.97M-29.01%
2020277.45M-2937.21%
2019-9778844.90-118.75%
201952.16M-91.31%
2018600.55M26.93%
2017473.13M33.38%

Summit Therapeutics Inc. (SMMT) Average Enterprise Value

How has SMMT Enterprise Value performed in the past?

The current Enterprise Value of Summit Therapeutics Inc. (SMMT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

9.08B

5-year avg

5.68B

10-year avg

2.98B

Summit Therapeutics Inc. (SMMT) Enterprise Value vs. Peers

How is SMMT’s Enterprise Value compared to its peers?

Summit Therapeutics Inc.’s Enterprise Value is less than Roivant Sciences Ltd. (20.29B), less than BridgeBio Pharma, Inc. (15.59B), less than Revolution Medicines, Inc. (32.43B), less than Ascendis Pharma A/S (11.98B), less than Ionis Pharmaceuticals, Inc. (13.98B), less than Exact Sciences Corporation (21.59B), less than Royalty Pharma plc (31.97B), less than Moderna, Inc. (19.19B), greater than Atrium Therapeutics, Inc. (-53572208.00), less than Universal Health Services, Inc. (14.17B),

Build a custom stock screener for Summit Therapeutics Inc. (SMMT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Summit Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Summit Therapeutics Inc. (SMMT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Summit Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Summit Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Summit Therapeutics Inc. (SMMT)?

What is the 3-year average Enterprise Value for Summit Therapeutics Inc. (SMMT)?

What is the 5-year average Enterprise Value for Summit Therapeutics Inc. (SMMT)?

How does the current Enterprise Value for Summit Therapeutics Inc. (SMMT) compare to its historical average?